Posts Tagged ‘ biotechnology ’

EANS-News: Sangui Bio Tech International Inc. / Continuous trading in Sangui…

March 22, 2013
By
EANS-News: Sangui Bio Tech International Inc. / Continuous trading in Sangui…

-------------------------------------------------------------------------------- Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- Financing, Stock Offerings (IPO) Witten, Germany, March 22, 2012 (euro adhoc) - Continuous trading in Sangui shares restored in German markets Additional listing on Berlin stock exchange As of today, the shares of Sangui BioTech International,…

Read more »

EANS-News: Intercell AG / Vivalis SA shareholders approved the proposed merger of equals to create Valneva SE

March 7, 2013
By
EANS-News: Intercell AG / Vivalis SA shareholders approved the proposed merger of equals to create Valneva SE

-------------------------------------------------------------------------------- Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- Company Information Wien (euro adhoc) - Nantes (France), Vienna (Austria), March 7, 2013 - Intercell AG (VSE: ICLL) and Vivalis SA (NYSE Euronext: VLS) today announced that the Extraordinary General Meeting of both companies approved the…

Read more »

EANS-News: Epigenomics AG Enrolls First Participant in its FIT comparative study with Epi proColon®

April 11, 2012
By

-------------------------------------------------------------------------------- Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- Company Information/New Products/molecular diagnostics Berlin, Germany, and Seattle, WA, U.S.A., April 11, 2012 (euro adhoc) - Epigenomics AG (Frankfurt Prime Standard: ECX), the German-American cancer molecular diagnostics company, today announced the start of the head-to-head comparative…

Read more »

EANS-General Meeting: Epigenomics AG / Additional Information for the General Meeting (with document)

March 23, 2012
By

-------------------------------------------------------------------------------- General meeting information transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- Please find the full text of the announcement here (en). http://resources.euroadhoc.com/us/8cZEFkS7 issuer : Epigenomics AG ... : Kleine Prsidentenstr. 1 ... : 10178 Berlin ... : de phone : +49 30 24345386 FAX : +49 30…

Read more »

EANS-News: Intercell AG / Intercell starts a pivotal Phase II/III efficacy study with its Pseudomonas aeruginosa vaccine candidate

March 13, 2012
By

-------------------------------------------------------------------------------- Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- Research & Development Wien (euro adhoc) - Vienna (Austria), March 13, 2012 - Today Intercell AG (VSE: ICLL) announced the start of a pivotal Phase II/III efficacy trial of its investigational Pseudomonas aeruginosa vaccine. The trial…

Read more »

Archives

Tags

apple apps Arne Arne Ruhnau Asia auto bbc digital domain europe Facebook finanzen free gesundheit googl google+ images immobilien index ipad iphone itc keywords king kultur line links location media medium mobile News nik path politik reise rim Ruhnau sport twitter video videos wirtschaft wissen wissenschaft